Lipidil

Lipidil Brand names, Lipidil Analogs

Lipidil Brand Names Mixture

No information avaliable

Lipidil Chemical_Formula

C₂₀H₂₁ClO₄

Lipidil RX_link

http://www.rxlist.com/cgi/generic3/fenofibrate.htm

Lipidil fda sheet

Lipidil FDA

Lipidil msds (material safety sheet)

Lipidil MSDS

Lipidil Synthesis Reference

No information avaliable

Lipidil Molecular Weight

360.831 g/mol

Lipidil Melting Point

80.5 °C

Lipidil H₂O Solubility

0.25mg/ml at 25 °C

Lipidil State

Solid

Lipidil LogP

5.575

Lipidil Dosage Forms

Capsule; Tablet

Lipidil Indication

For use as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb)

Lipidil Pharmacology

Fenofibrate is a lipid regulating agent indicated as adjunctive therapy to diet to reduce elevated LDL-C, Total-C,Triglycerides and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb). Fenofibrate is also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (Fredrickson Types IV and V hyperlipidemia). Fenofibric acid, the active metabolite of Fenofibrate, produces reductions in total cholesterol, LDL cholesterol, apolipoprotein B, total triglycerides and triglyceride rich lipoprotein (VLDL) in treated patients. In addition, treatment with fenofibrate results in increases in high density lipoprotein (HDL) and apoproteins apoAI and apoAII.

Lipidil Absorption

Fenofibrate is well absorbed from the gastrointestinal tract. After absorption, fenofibrate is mainly excreted in the urine in the form of metabolites, primarily fenofibric acid and fenofibric acid glucuronide

Lipidil side effects and Toxicity

LD₅₀=1600 mg/kg (Oral, in mice); Investigated as a teratogen and reproductive hazard.

Lipidil Patient Information